Intuitive Surgical Surges 0.42% on Strong Q2 Results as $1.43 Billion Volume Ranks 64th in Market Activity

On August 1, 2025, Intuitive Surgical (ISRG) traded with a volume of $1.43 billion, ranking 64th in market activity. The stock rose 0.42% to $483.00, reflecting modest gains amid broader market fluctuations.

Intuitive reported strong Q2 2025 results, with revenue climbing 21% year-over-year to $2.44 billion. The growth was driven by a 17% increase in procedure volumes and the deployment of 395 da Vinci surgical systems globally. Notably, 180 of these were the newer da Vinci 5 models, up from 70 in the prior year. The installed base of systems now totals 10,488, a 14% increase. The da Vinci 5 rollout remains central to the company’s momentum, with recent EU certification for adult and pediatric procedures across multiple specialties and expanded clearance in Japan.

Intuitive also updated its 2025 gross margin outlook to 66%, adjusting for tariff effects, and reaffirmed 15–17% global procedure growth expectations. The company’s focus on innovation and market expansion underscores its position in the robotic surgery sector, as hospitals address surgical backlogs and adopt advanced technologies.

The strategy of purchasing the top 500 stocks by daily trading volume and holding them for one day delivered a 166.71% return from 2022 to the present, outperforming the benchmark return of 29.18% by 137.53%. This highlights the role of liquidity concentration in short-term performance, particularly in volatile markets.